WebMar 2, 2024 · Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today... WebMar 2, 2024 · SAN DIEGO, March 02, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today announced concurrent but separate underwritten public offerings of its common stock …
Cidara Therapeutics, Inc. (CDTX) Stock Price, Quote
WebThe latest price target for Cidara Therapeutics ( NASDAQ: CDTX) was reported by HC Wainwright & Co. on Friday, March 24, 2024. The analyst firm set a price target for 6.00 expecting CDTX to rise ... WebWe offer only the best in quality and technology for installation companies who seek the most superior turf products. Health11News has awarded three nutritional supplement … shrek construction
CDTX Price Target 2024 Cidara Therapeutics Analyst Ratings
WebOct 8, 2024 · Cidara Therapeutics (NASDAQ: CDTX) priced of a public offerings of ~14.84M common shares at $1.55/share and ~774.2K shares of its Series X Convertible Preferred Stock at $15.50/share. The gross... WebHow to buy CDTX stock on Public 1 Sign up for a brokerage account on Public It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android. 2 Add funds to your Public account WebApr 10, 2024 · Cidara Therapeutics (NASDAQ:CDTX) has a recorded net income of -$29.80 million. CDTX has generated -$0.48 earnings per share over the last four quarters. What is Cidara Therapeutics's EPS forecast for next year? Cidara Therapeutics's earnings are expected to decrease from ($0.31) per share to ($0.45) per share in the … shrek contract